Swiss Lonza to acquire German Merck's production facility as CDMO companies expand into new areas (JoongAng Ilbo Japanese Edition)

Swiss Lonza is expected to acquire a production facility owned by German pharmaceutical company Merck, with reports indicating that its expansion into new areas as a CDMO company is progressing.

Full text unavailableWorking from the headline and excerpt

sources corroborateOutlets reporting the same event

companies linkedAcross 0 themes, second pass

The story

Lonza, a CDMO company headquartered in Basel, Switzerland, is reportedly seeking to expand its business operations through the acquisition of a Merck production facility.

The article does not provide details such as the specific timing or purchase price of the acquisition, and further information is awaited.

At a glance

Reporting entityLonza to acquire Merck's production facility

InstrumentMerck's production facility

CharacteristicsAcquisition aimed at expanding in the CDMO sector

Reference information. Every claim resolves to something the story actually named.

Where this came from

We read each source in full and checked they agree on the core claim.

1/ 1 agree

All of them report the same thing.

google.comNews

AgreesOpen

Read the original articleGo to the source page

Reference information generated from public sources. It does not solicit or advise on investments. Prices are 15-minute delayed.